DNA X, Inc. 8-K

What Happened
On May 20, 2026, DNA X, Inc. (NASDAQ: SONM) announced its financial results for the fiscal quarter ended March 31, 2026 via a press release. The company furnished that press release as Exhibit 99.1 to a Current Report on Form 8-K (Item 2.02—Results of Operations and Financial Condition).

Key Details

• Filing date: May 20, 2026 (Form 8‑K, Item 2.02).
• Reporting period: fiscal quarter ended March 31, 2026.
• Disclosure: Press release announcing the quarterly results furnished as Exhibit 99.1.
• The filing also includes the cover page interactive XBRL file (Exhibit 104).

Why It Matters
This 8‑K signals that DNA X has released its latest quarterly earnings and financial condition information — key data points (revenue, net income/loss, cash position, and any commentary on operations or outlook) are contained in the press release. Retail investors should read Exhibit 99.1 to see the actual earnings and revenue figures and monitor the company’s subsequent periodic filings (including the 10‑Q) for full financial statements and management discussion, as these items can affect investment decisions and the stock price.